Loading chat...
NY A09583
Bill
Status
1/21/2026
Primary Sponsor
Robert Smullen
Click for details
AI Summary
-
Creates a competitive grant program administered by the New York Health Commissioner to fund FDA-compliant Phase II or Phase III clinical trials of ibogaine for treating PTSD in veterans
-
Requires grantees to provide dollar-for-dollar matching funds from non-state sources before receiving state disbursements
-
Gives preference to applicants who commit to establishing a physical presence in New York and include veterans in trial design, recruitment, and aftercare plans
-
Establishes an advisory committee with subject matter experts in clinical trials, PTSD, psychiatry, and veteran mental health, plus legislative appointees, to review applications and recommend awards
-
Automatically repeals after 10 years or 5 years after FDA approves ibogaine for any indication, whichever occurs sooner
Legislative Description
Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program.
Last Action
referred to health
1/21/2026